Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Cellular Immunotherapy Market Size From 2025 to 2034?

The market size for cellular immunotherapy has seen a quick rise in the past few years. The forecasted growth stages it to expand from $5.72 billion in 2024 to $6.56 billion in 2025, projecting a compound annual growth rate (CAGR) of 14.7%. This significant growth during the historical period is linked to developments in cancer treatment, triumphant clinical anecdotes, regulatory endorsements, and an increasing occurrence of targeted diseases.

The size of the cellular immunotherapy market is projected to experience swift expansion in the upcoming years, surging to a value of $11.03 billion by 2029, portraying a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this growth during the projected period include advancements in treating solid tumors, enhancements in manufacturing and healthcare infrastructure, and increases in research funding. The forecast period is also anticipated to witness significant developments, including investments in research and development, clinical trial data, and the advent of combination therapies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

Which Factors and External Forces Are Driving Demand in the Cellular Immunotherapy Market?

The cellular immunotherapy market’s growth is anticipated to be fuelled by escalating research efforts and successful clinical trials in this field during the forecast period. Various companies are concentrating on the production of innovative cellular immunotherapies to combat various conditions. As an example, the Cancer Research Institute, an American non-profit organisation committed to creating immunotherapy for the prevention, treatment and removal of all types of cancer, issued a report in June 2022 stating that as of April 2022, there were 2,756 operational cell therapy drugs globally in the immuno-oncology pipeline. This is a growth of 36% from 2021, which had 2,031 such therapies – a slight decline from the 43% growth reported in the preceding year. The substantial increase in the number of cellular immunotherapies in clinical trials and preclinical stages in 2020, compared to those in 2019, is predicted to widen the spectrum of cellular immunotherapy, thus contributing to more substantial revenue generation and expansion of the cellular immunotherapy market.

Which Segments in the Cellular Immunotherapy Offer the Most Growth?

The cellular immunotherapy market covered in this report is segmented –

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Subsegments:

1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy, Allogeneic TIL Therapy, Other TIL Therapy

2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy, Other Engineered TCR Therapy

3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies, Other CAR T Cell Therapy

4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications, Other NK Cell Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3435&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Cellular Immunotherapy Market?# Market?

North America was the largest region in the cellular immunotherapy market in 2024. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theCellular Immunotherapy Market’s Growth?

In the cellular immunotherapy market, the focus is shifting towards the creation of off-the-shelf allogeneic therapies for enhanced cancer treatment. These therapies differ from traditional autologous therapy in that they are derived from donor cells rather than the cells of the patient. The uniform nature of these therapies offers benefits such as cost efficiency, mass production, swift production, and quality assurance. For example, in May 2022, the US FDA approved Kymriah (tisagenlecleucel) for the treatment of adult patients with relapsing or refractory (r/r) follicular lymphoma (FL) after two or more courses of systemic therapy. This announcement was made by Novartis AG, a Swiss pharmaceutical firm with expertise in drug discovery, development, production, and commercialization. Furthermore, Acepodia, a US biotech firm specializing in next-generation cell immunotherapy, is set to commence a phase 1 clinical trial in August 2020 to assess the efficacy of ACE1702, an allogeneic, off-the-shelf NK cell therapy, in treating solid tumors.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

What Are the Key Elements That Define the Cellular Immunotherapy Market?

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body’s immune system to combat cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3435

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model